Passage Bio, Inc. (PASG)
4.43
0.00 (0.00%)
USD |
NASDAQ |
Sep 01, 11:38
Passage Bio Cash and Short Term Investments (Quarterly) : 24.16M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 24.16M |
| March 31, 2026 | 33.34M |
| December 31, 2025 | 46.30M |
| September 30, 2025 | 52.77M |
| June 30, 2025 | 57.63M |
| March 31, 2025 | 63.36M |
| December 31, 2024 | 76.76M |
| September 30, 2024 | 84.83M |
| June 30, 2024 | 91.77M |
| March 31, 2024 | 104.52M |
| December 31, 2023 | 114.29M |
| September 30, 2023 | 132.78M |
| June 30, 2023 | 151.48M |
| March 31, 2023 | 167.77M |
| December 31, 2022 | 189.61M |
| September 30, 2022 | 213.76M |
| Date | Value |
|---|---|
| June 30, 2022 | 239.25M |
| March 31, 2022 | 267.09M |
| December 31, 2021 | 315.77M |
| September 30, 2021 | 354.40M |
| June 30, 2021 | 407.80M |
| March 31, 2021 | 437.59M |
| December 31, 2020 | 304.82M |
| September 30, 2020 | 335.70M |
| June 30, 2020 | 353.42M |
| March 31, 2020 | 366.83M |
| December 31, 2019 | 158.87M |
| September 30, 2019 | 177.19M |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 24.86M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| ARS Pharmaceuticals, Inc. | 143.84M |
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Alnylam Pharmaceuticals, Inc. | 3.308B |
| Anika Therapeutics, Inc. | 38.41M |
| Savara, Inc. | 173.03M |